Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Anavasi Diagnostics
AddedFeb 15, 2024
UpdatedJun 18, 2026
Anavasi Diagnostics

Anavasi Diagnostics

Seed

Anavasi Diagnostics: Rapid, affordable COVID-19 testing through advanced molecular technology.

HQ
Seattle, WA, US
Founded
2021
Overview
Compare
Fundraising
Employees
Website

Founded with a mission to provide rapid, precise, and affordable diagnostic solutions, Anavasi Diagnostics focuses on the development of advanced molecular diagnostic testing. Their flagship product, the AscencioDx® Molecular Detector, is a portable diagnostic tool that delivers results in as few as 20 minutes. This innovative device is designed for use in various medical settings, including physicians' offices, urgent care clinics, and pharmacies, making it a vital tool in point-of-care facilities.

Anavasi Diagnostics has garnered significant support and recognition, notably being selected by the National Institutes of Health (NIH) for the highly competitive RADx® development program. This endorsement underscores their commitment to advancing healthcare through cutting-edge technology. The company's rapid and efficient diagnostic solutions have made a substantial impact in the medical field, particularly during the COVID-19 pandemic, by enabling timely and accurate testing.

Anavasi Diagnostics - Similar Companies

NAT Diagnostics logo

NAT Diagnostics

Instadiagnostics logo

Instadiagnostics

Minute Molecular Diagnostics logo

Minute Molecular Diagnostics

Prompt Diagnostics logo

Prompt Diagnostics

prompt-dx.com

Prominex logo

Prominex

prominex.com

Molecular Detection logo

Molecular Detection

Test Diagnostics logo

Test Diagnostics

In Diagnostics logo

In Diagnostics

indiagnostics.com

Novel Microdevices logo

Novel Microdevices

noveldx.com

Nanopath logo

Nanopath

nanopathdx.com

AmplifiDx logo

AmplifiDx

amplifidx.com

Burst Diagnostics logo

Burst Diagnostics

burst-dx.com

Diagmetrics logo

Diagmetrics

diagmetrics.com

Evanostics logo

Evanostics

Proxim Diagnostics logo

Proxim Diagnostics

proximdx.com

Anavasi Diagnostics - Quick Facts

Who are Anavasi Diagnostics' competitors?

Companies similar to Anavasi Diagnostics include NAT Diagnostics, Instadiagnostics, Minute Molecular Diagnostics and Prompt Diagnostics.

When was Anavasi Diagnostics founded?

Anavasi Diagnostics was founded in 2021.

Where is Anavasi Diagnostics' headquarters located?

Anavasi Diagnostics' headquarters is located in Seattle, WA, US.

When was Anavasi Diagnostics' last funding round?

Anavasi Diagnostics' most recent funding round was for $2.6M (USD) in January 2022.

How much has Anavasi Diagnostics raised to-date?

As of Jan 12, 2022, Anavasi Diagnostics has raised a total of $23.5M (USD).

How many employees does Anavasi Diagnostics have?

Anavasi Diagnostics has 33 employees as of Feb 4, 2024.

Anavasi Diagnostics - Classification

Industry
  • Hardware
Ownership
  • Venture Capital
Technology
  • Molecular Diagnostics
Geographic Exposure
  • United States
Revenue
  • Software
  • Transactional
Customer
  • Enterprise
  • Small Business
Main Product
  • Diagnostic Tests
Tags
  • Biotech
  • Healthtech
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 325000Chemical Manufacturing
  • 325410Pharmaceutical and Medicine Manufacturing
SIC
  • 5000Wholesale Trade-durable Goods
  • 5040Professional And Commercial Equipment And Supplies
  • 5047Medical, Dental, And Hospital Equipment And Supplies
Show 7 more industry codes
NAICS
  • 330000Manufacturing
  • 620000Health Care and Social Assistance
  • 623000Nursing and Residential Care Facilities
SIC
  • 3900Miscellaneous Manufacturing Industries
  • 8000Health Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified